• Company
• Lagevrio was voluntarily withdrawn from Europe
• by Kim, Jin-Gu Jul 3, 2023 05:47am

• Company
• Leclaza and Tagrisso compete for reimb in the first line
• by Jung, Sae-Im Jul 3, 2023 05:47am

• Policy
• Drug price negotiations such as Roche Evrysdi begin
• by Lee, Tak-Sun Jul 3, 2023 05:47am

• Company
• Pfizer, Lilly, AbbVie engage in JAKi battle in KOR
• by Nho, Byung Chul Jul 3, 2023 05:47am

• Company
• Illaris for 13 pts, re-challenge to enter insurance benefit
• by Eo, Yun-Ho Jul 3, 2023 05:45am

• Company
• Imfinzi+Imjudo combo approved for liver cancer in KOR
• by Eo, Yun-Ho Jul 3, 2023 05:45am

• Policy
• Eval period for HCV treatment shortened to 12 weeks from 24
• by Lee, Hye-Kyung Jun 30, 2023 06:01am

• Company
• Oral AML drug Onureg can be prescribed at general hospitals
• by Eo, Yun-Ho Jun 30, 2023 06:01am

• Policy
• Tx for combi of dementia/hyperlipidemia have increased
• by Lee, Tak-Sun Jun 30, 2023 06:01am

• Opinion
• [Reporter's view] Signs of concern about the Saxenda craze
• by Jun 29, 2023 05:56am